share_log

FDA Said Medtronic Conducted Recall of Heartware Ventricular Assist Device System to Inform Health Care Providers, Patients of Battery Performance Issues; Provided Information About HVAD System's Battery Electrical Faults Caused by Interaction Between Bat

FDA Said Medtronic Conducted Recall of Heartware Ventricular Assist Device System to Inform Health Care Providers, Patients of Battery Performance Issues; Provided Information About HVAD System's Battery Electrical Faults Caused by Interaction Between Bat

FDA表示，美敦力召回了心臟輔助裝置系統，以告知醫護人員和患者電池性能問題；提供了BAT之間相互作用導致的HVAD系統電池電氣故障的信息
Benzinga Real-time News ·  2022/07/01 03:45

FDA Said Medtronic Conducted Recall of Heartware Ventricular Assist Device System to Inform Health Care Providers, Patients of Battery Performance Issues; Provided Information About HVAD System's Battery Electrical Faults Caused by Interaction Between Battery Software and Internal Component

FDA表示，美敦力召回了心臟輔助裝置系統，以告知醫護人員和患者電池性能問題；提供了由於電池軟件和內部組件相互作用而導致的HVAD系統電池電氣故障的信息

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論